Meadow Creek Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.19M | Sell |
8,960
-5,628
| -39% | -$745K | 0.02% | 442 |
|
|
2019
Q2 | $2.07M | Buy |
14,588
+3,220
| +28% | +$457K | 0.04% | 330 |
|
|
2019
Q1 | $1.65M | Buy |
11,368
+3,416
| +43% | +$496K | 0.03% | 362 |
|
|
2018
Q4 | $900K | Sell |
7,952
-1,904
| -19% | -$215K | 0.02% | 453 |
|
|
2018
Q3 | $1.33M | Buy |
9,856
+1,344
| +16% | +$181K | 0.03% | 395 |
|
|
2018
Q2 | $956K | Sell |
8,512
-4,424
| -34% | -$497K | 0.02% | 450 |
|
|
2018
Q1 | $1.38M | Sell |
12,936
-84
| -0.6% | -$8.97K | 0.03% | 353 |
|
|
2017
Q4 | $1.43M | Buy |
13,020
+7,476
| +135% | +$818K | 0.03% | 376 |
|
|
2017
Q3 | $599K | Buy |
5,544
+840
| +18% | +$90.8K | 0.01% | 548 |
|
|
2017
Q2 | $476K | Buy |
4,704
+560
| +14% | +$56.7K | 0.01% | 613 |
|
|
2017
Q1 | $373K | Sell |
4,144
-168
| -4% | -$15.1K | 0.01% | 617 |
|
|
2016
Q4 | $329K | Buy |
+4,312
| New | +$329K | 0.01% | 608 |
|